SEC: Trading scheme involved confidential government information

The Securities and Exchange Commission has announced alleged insider-trading charges in a plot that used non-public government information to affect the value of publicly traded medical stocks.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.